ATCC® High-titer, Purified Respiratory Syncytial Virus - New!
Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis and pneumonia in infants less than 1 year of age, and has been recognized as an important cause of respiratory illness in adults1. There is no vaccine for RSV, and previous exposure does not provide complete immunity against re-exposure.
ATCC now offers a high-titer, sucrose-cushion purified RSV A-2 strain (ATCC® VR-1540P) for use in RSV research. Each ampoule contains 200µL of purified virus at a concentration >2 x 108 PFU/mL, and is useful in a variety of applications where high titer material is required, such as challenge studies and viral clearance assays.
To request custom high-titer, purified virus from other ATCC viral cultures, please contact us at firstname.lastname@example.org.
1 Respiratory Syncytial Virus (RSV): Incidence and Infection. CDC. Available on the web at www.cdc.gov/rsv/about/infection.html.
Tags: Respiratory Syncytial Virus
Date Published: July 2, 2012 » company contact details
Discover VirClia®, Chemiluminescence in Monotest That Adapts to Your Lab
CE Marked 30 Minute Or Less Molecular Flu/RSV Test
New BD Veritor™ Plus System for Secure, Traceable POC
ARIES® Flu A/B & RSV Assay Receives CE-IVD Mark
EpiCast Report: RSV Infection - Epidemiology Forecast to 2024